We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$4.19B
AUM Growth
+$135M
Cap. Flow
+$49.5M
Cap. Flow %
1.18%
Top 10 Hldgs %
44.67%
Holding
487
New
37
Increased
209
Reduced
193
Closed
27

Sector Composition

Rank Sector Weight
1 Technology 13.7%
2 Healthcare 5.68%
3 Financials 4.5%
4 Communication Services 3.15%
5 Industrials 2.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
26
JPMorgan Chase
JPM
$933B
$31.5M 0.75%
97,824
+542
+0.6% +$168K
AVLC icon
27
Avantis US Large Cap Equity ETF
AVLC
$1.36B
$30.7M 0.73%
390,848
+63,790
+20% +$4.95M
META icon
28
Meta Platforms (Facebook)
META
$1.37T
$28.7M 0.69%
43,438
-7,453
-15% -$4.98M
GOOG icon
29
Alphabet (Google) Class C
GOOG
$4.08T
$27.9M 0.67%
88,815
+1,211
+1% +$347K
AVGO icon
30
Broadcom
AVGO
$1.85T
$27.5M 0.66%
79,322
-8,594
-10% -$3.07M
QCOM icon
31
Qualcomm
QCOM
$160B
$27.3M 0.65%
159,633
-9,271
-5% -$1.59M
AMGN icon
32
Amgen
AMGN
$209B
$26.9M 0.64%
82,129
-4,111
-5% -$1.3M
ABBV icon
33
AbbVie
ABBV
$455B
$25M 0.6%
109,214
+2,228
+2% +$508K
RMIF
34
DELISTED
LHA Risk-Managed Income ETF
RMIF
$24.2M 0.58%
976,048
-34,394
-3% -$857K
JNJ icon
35
Johnson & Johnson
JNJ
$617B
$23.7M 0.57%
114,421
-3,291
-3% -$651K
RF icon
36
Regions Financial
RF
$26.3B
$22.9M 0.55%
846,350
-57,733
-6% -$1.47M
XLP icon
37
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.3B
$21.7M 0.52%
279,265
-93,789
-25% -$7.32M
XLI icon
38
State Street Industrial Select Sector SPDR ETF
XLI
$32.5B
$21.5M 0.51%
138,742
+2,266
+2% +$349K
PFE icon
39
Pfizer
PFE
$142B
$19.7M 0.47%
789,950
+684,303
+648% +$17.3M
AMD icon
40
Advanced Micro Devices
AMD
$791B
$19.5M 0.47%
90,890
-22,530
-20% -$5.06M
SGOV icon
41
iShares 0-3 Month Treasury Bond ETF
SGOV
$99.4B
$19.1M 0.46%
+190,372
New +$19.1M
JIRE icon
42
JPMorgan International Research Enhanced Equity ETF
JIRE
$11.3B
$18.8M 0.45%
250,644
+61,234
+32% +$4.57M
ETN icon
43
Eaton
ETN
$150B
$18.8M 0.45%
58,910
-5,671
-9% -$2.01M
BMY icon
44
Bristol-Myers Squibb
BMY
$132B
$18.8M 0.45%
347,619
-28,024
-7% -$1.35M
CSCO icon
45
Cisco
CSCO
$448B
$18.7M 0.45%
242,453
-6,247
-3% -$464K
GILD icon
46
Gilead Sciences
GILD
$163B
$18.5M 0.44%
150,368
-9,777
-6% -$1.19M
V icon
47
Visa
V
$673B
$18.4M 0.44%
52,384
-369
-0.7% -$126K
DFAE icon
48
Dimensional Emerging Core Equity Market ETF
DFAE
$9.24B
$17.9M 0.43%
549,450
+54,570
+11% +$1.76M
HPE icon
49
Hewlett Packard
HPE
$62.4B
$17.5M 0.42%
728,586
-78,394
-10% -$1.85M
MDT icon
50
Medtronic
MDT
$110B
$17.2M 0.41%
179,519
-10,223
-5% -$993K

Similar funds

Grimes & Company's Q4 2025 Portfolio in Review

As of Q4 2025, Grimes & Company held 487 positions worth $4.19B, up 3.3% from $4.05B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Grimes & Company's Q4 2025 filing shows 37 new, 209 increased, 193 reduced and 27 closed positions. Its largest new stake was iShares 0-3 Month Treasury Bond ETF: 190,372 shares worth $19.1M. The largest sale was State Street Materials Select Sector SPDR ETF, an estimated $20.5M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Financials.

  • Grimes & Company's largest Q4 2025 buy was iShares 0-3 Month Treasury Bond ETF: 190,372 shares worth $19.1M.
  • Grimes & Company added most to State Street Health Care Select Sector SPDR ETF in Q4 2025, an estimated $35.7M increase.
  • Grimes & Company's biggest Q4 2025 reduction was Invesco S&P 500 Equal Weight ETF, cutting an estimated $14.7M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q4 2025, selling an estimated $20.5M.
  • Grimes & Company's ten largest holdings make up 45% of its $4.19B portfolio in Q4 2025.
  • Grimes & Company opened 37 new positions and closed 27 in Q4 2025.
  • Grimes & Company's portfolio value rose 3.3% quarter-over-quarter to $4.19B.

Based on Grimes & Company's 13F filing for Q4 2025, filed 3 Feb 2026.